# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!



Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 441-450 of 495 results.
Hepatitis C Virus (HVC) Positive Heart Grafts in HCV Negative Recipients
Status: Recruiting
Last Changed: Oct 14, 2020
First Received: Jun 30, 2020
Disease(s): Heart Failure
Intervention(s): Procedure: Heart Transplantation
Locations: Loma Linda University Transplant Institute, Loma Linda, California, United States
Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand
Status: Recruiting
Last Changed: Jul 20, 2020
First Received: Jun 12, 2020
Disease(s): Pertussis Immunisation, Diphtheria Immunisation, Polio Immunisation, Hepatitis B Immunisation, Haemophilus Influenzae Type B Immunisation, Tetanus Immunisation, Rotavirus Immunisation, Pneumococcal Immunisation
Intervention(s): DTwP-HepB-Hib-IPV hexavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b, inactivated poliovirus), DTwP-HepB-Hib pentavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b), Inactivated Poliomyelitis Vaccine, Poliomyelitis Vaccine bivalent types 1 and 3, Human Rotavirus, live attenuated, Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)
Locations: Investigational Site Number 7640003, Bangkok, Thailand
Investigational Site Number 7640001, Bangkok, Thailand
Investigational Site Number 7640002, Khonkaen, Thailand
Elimination of HCV Through Linkage and In Prison Treatment of Incarcerated Populations (ECLIPSE)
Status: Not yet recruiting
Last Changed: Nov 03, 2020
First Received: Jan 21, 2020
Disease(s): HCV Infection
Intervention(s): Glecaprevir/pibrentasvir
Locations: Baltimore City Detention Center, Baltimore, Maryland, United States
P1101 and Anti-PD1 for After Curative Surgery of Hepatitis B-related Hepatocellular Carcinoma
Status: Recruiting
Last Changed: Jan 18, 2020
First Received: Jan 18, 2020
Disease(s): Hepatocellular Carcinoma
Intervention(s): P1101 (Ropeginterferon alfa-2b), Nivolumab
Locations: National Taiwan university Hospital, Taipei city, Taiwan
Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection
Status: Recruiting
Last Changed: Apr 04, 2019
First Received: Apr 04, 2019
Disease(s): Chronic HBV Infection
Intervention(s): HS-10234, TDF
Locations: The First Hospital of Jilin University, Changchun, Jilin, China
Development and Validation of a Screening Score for the Biliary Atresia in Infantile Cholestasis: A Prospective Study
Status: Recruiting
Last Changed: Feb 19, 2019
First Received: Feb 15, 2019
Disease(s): Biliary Atresia, Neonatal Cholestasis, Infantile Hepatitis Syndrome
Intervention(s): biliary atresia screen score
Locations: Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Efficacy and Safety of Anti HCV Drugs in the Treatment of COVID-19
Status: Not yet recruiting
Last Changed: Jun 25, 2020
First Received: Jun 23, 2020
Disease(s): COVID-19
Intervention(s): Hydroxychloroquine , Sofosbuvir, daclatasvir, Standard of care treatment
EUS Guided Portal-systemic Pressure Gradient Measurement
Status: Recruiting
Last Changed: Nov 18, 2020
First Received: Nov 18, 2020
Disease(s): Portal Hypertension, Cirrhosis
Intervention(s): EUS-portal pressure gradient measurement (PPGM)
Locations: Chinese University of Hong Kong, Hong Kong, Hong Kong, China
Adjuvant Entecavir for Postoperative HBV-HCC
Status: Recruiting
Last Changed: Jul 22, 2020
First Received: Jan 08, 2016
Disease(s): Hepatocellular Carcinoma
Intervention(s): Entecavir, Lamivudine
Locations: Department of Hepatobilliary Surgery, Affiliated Tumor of Guangxi University, Nanning, Guangxi, China
Marginal Zone Lymphoma Cohort in Korea
Status: Recruiting
Last Changed: Apr 18, 2018
First Received: Apr 08, 2016
Disease(s): Lymphoma, B-Cell, Marginal Zone
Intervention(s): Rituximab
Locations: Sung Yong Oh, Busan, Korea, Republic of